Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Denisa Pohanková"'
Autor:
Iveta Kolářová, Bohuslav Melichar, Igor Sirák, Jaroslav Vaňásek, Jiří Petera, Kateřina Horáčková, Denisa Pohanková, Filip Ďatelinka, Zuzana Šinkorová, Milan Vošmik
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1207-1220 (2024)
The role of postmastectomy radiotherapy and regional nodal irradiation after radical mastectomy is defined in high-risk patients with locally advanced tumors, positive margins, and unfavorable biology. The benefit of postmastectomy radiotherapy in in
Externí odkaz:
https://doaj.org/article/fc0a53d8646a410ba62dda07b6301b90
Publikováno v:
Onkologie. 16:312-316
Autor:
Denisa Pohanková, Jindřich Kopecký
Publikováno v:
Onkologie. 14:213-218
Autor:
Veronika Novotná, Jakub Grepl, Petr Motyčka, Jiří Petera, Ahmed Asqar, Lucie Kretzler, Linda Kašaová, Denisa Pohanková, Igor Sirák, Pavel Jandík, Petr Paluska
Publikováno v:
Strahlentherapie und Onkologie. 197:288-295
To quantify mean heart dose (MHD) and doses to the left anterior descending artery (LAD) and left ventricle (LV) in a retrospective series of patients who underwent perioperative accelerated partial breast irradiation with multicatheter interstitial
Publikováno v:
Onkologie. 14:13-17
Východiska: Chemoterapie (CHT) je důležitou modalitou využivanou v lecbě nadorových onemocněni. V užsim smyslu se pod pojmem chemoterapie rozumi lecba cytostatiky. Tato lecba je spojena s množstvim nežadoucich ucinků (NU), ktere jsme v sou
Autor:
Jakub Grepl, Petr Paluska, Eva Hovorková, Igor Sirák, Miroslav Hodek, Milan Vošmik, David Buka, Denisa Pohanková, Tomáš Rozkoš, Jiří Petera, Alexander Ferko
Publikováno v:
Pathology & Oncology Research. 26:1565-1572
Total mesorectal excision quality (TMEq) is a prognostic factor associated with local recurrence in rectal adenocarcinoma. Neoadjuvant chemoradiotherapy (NCRT) reduces the risk of tumor recurrence, but may compromise TMEq. The time between NCRT and s
Autor:
Jiří Petera, Vladimír Ninger, Jakub Grepl, Denisa Pohanková, Igor Sirák, Petr Paluska, Viliam Kopecky, Petr Motyčka, Ahmed Asqar, Pavel Jandík, Linda Kašaová, Ivana Bydžovská
Publikováno v:
Brachytherapy. 17:949-955
Purpose To assess the feasibility of high-dose-rate perioperative multicatheter interstitial brachytherapy to deliver accelerated partial breast irradiation (APBI) in selected patients with early breast cancer. Methods and Materials Perioperative mul
Autor:
Jakub Grepl, Lucie Kretzler, Igor Sirák, Jiří Petera, Denisa Pohanková, Petr Paluska, Veronika Novotná, Ahmed Asqar, Pavel Jandík, Petr Motyčka, Linda Kašaová
Publikováno v:
Strahlentherapie und Onkologie. 197:461-462
Autor:
Jakub Grepl, Igor Sirák, Miroslav Louda, Denisa Pohanková, Jiří Petera, Jiří Špaček, Petr Prošvic, Linda Kašaová, Lukáš Holub, Petr Paluska
Publikováno v:
Klinicka Onkologie. 32
Background Interstitial low dose rate brachyther-apy is established organ spar-ing treatment of T1- T2 penile carcinoma. Experience with high-dose rate brachyther-apy is limited in this indication. Materials and methods Twenty-six patients with early
Autor:
Zuzana Pleskacova, Michael Bartos, Hana Vosmikova, Rafael Dolezal, Petr Krupa, Barbora Vitovcova, Petra Kasparova, Emil Rudolf, Veronika Skarkova, Denisa Pohankova, Veronika Novotna, Jiri Petera
Publikováno v:
Biomedicines, Vol 12, Iss 6, p 1210 (2024)
Background: Although several prognostic factors for survival have been identified in glioblastoma, there are numerous other potential markers (such as hemoglobin) whose role has not yet been confirmed. The aim of this study was to evaluate a wide ran
Externí odkaz:
https://doaj.org/article/ab1d1b26cf1b4391bed3f87122d98f20